Tag: Health care industry
-
Cyclospora outbreak tests RFK Jr.’s promise to overhaul food system, rebuild trust in CDC
Cyclospora presents a test for HHS Secretary Robert F. Kennedy Jr.’s promise to overhaul the food system and restore confidence in the agencies overseeing it.
-
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials
There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of its obesity portfolio.
-
Ozempic face? Botox maker reports boost from ‘sagging face’ trend
The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes dubbed “Ozempic face.”
-
This is the stock to buy after OpenAI’s AI agent goes rogue in a cybersecurity test
Jim Cramer said CrowdStrike is the stock to buy after OpenAI’s agentic breach.
-
Trump’s generic drug tariffs: What they could mean for medicine prices, manufacturers and supply
Trump’s generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.
-
RFK Jr. says cyclospora outbreak is ‘under control’
Health and Human Services Secretary Robert F. Kennedy Jr. on Tuesday said that the ongoing outbreak of cyclosporiasis is “under control” despite criticism.
-
Cardinal Health’s latest deals won’t move the needle overnight. They still matter.
Cardinal Health announced two tuck-in acquisitions Monday that further expand one of the fastest-growing parts of its business.
-
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo asked the court to permanently stop Lilly from running the “deceptive” ads and require the drugmaker to issue corrective advertising.
-
The FDA made a big reversal in its cyclosporiasis probe, but it still thinks iceberg lettuce is to blame
The FDA’s investigation into the source of the cyclosporiasis outbreak is causing confusion as companies and consumers alike navigate new updates.
-
What to know about testosterone replacement therapy as the U.S. military plans to test troops
While some research has shown benefits for patients who qualify, questions remain about the therapy’s long-term risks and use among men without a medical need.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany Investment strategy iran Iran war markets news People per politics return russia said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World world cup World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
